Search for Clinical Trial Results

Sponsored By

Richter Syndrome - 14 Studies Found

Status Study
Completed Study Name: Oxaliplatin, Fludarabine, Cytarabine and Rituximab in Richter's Syndrome, Refractory CLL and PLL
Condition: Leukemia
Date: 2007-03-23
Interventions:
  • Drug: Cytarabine 1 g/m^2 given
Completed Study Name: Study of Pembrolizumab in Combination With Ublituximab and TGR-1202 in Patients With Relapsed-refractory CLL or Richter's Transformation
Condition: Chronic Lymphocytic Leukemia
Date: 2015-08-24
Interventions:
  • Drug: Pembrolizumab IV immunot
Completed Study Name: Efficacy and Safety Study of PCI-32765 Combine With Ofatumumab in CLL
Condition:
  • B-cell Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Drug: PCI-32765 420 mg PO dail
Active, not recruiting Study Name: ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies
Condition:
  • Non-hodgkin Lymphoma
  • Multiple Myeloma
  • Hodgkin Lymphoma Date: 2015-02-07
    Interventions:
    • Drug: Acalabrutinib oral
<<< Previous